Old Web
English
Sign In
Acemap
>
authorDetail
>
Gcllsg
Gcllsg
Immunology
Medicine
Chronic lymphocytic leukemia
Chlorambucil
Internal medicine
3
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
No Significant Clinical Benefit of First Line Therapy with Fludarabine (F) in Comparison to Chlorambucil (Clb) in Elderly Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Phase III Study of the German CLL Study Group (GCLLSG).
2007
Blood
Barbara Eichhorst
Raymonde Busch
Martina Stauch
Manuela Bergmann
Matthias Ritgen
Nicole Kranzhöfer
Carmen D. Schweighofer
Kirsten Fischer
Anna Maria Fink
Paula Cramer
Valentin Goede
Clemens-M. Wendtner
Michael Hallek
Gcllsg
Show All
Source
Cite
Save
Citations (32)
Fludarabine induces higher response rates in first line therapy of older patients with advanced chronic lymphocytic leukemia than chlorambucil Interim analysis of a phase III study of the German CLL Study Group
2003
Blood
Barbara Eichhorst
Raymonde Busch
Martina Stauch
Michael Kneba
Matthias Ritgen
Ulrike Soeling
Oswald Burkhard
Manuela Bergmann
Clemens-M. Wendtner
Wolfgang Hiddemann
Bertold Emmerich
Michael Hallek
Gcllsg
Show All
Source
Cite
Save
Citations (17)
Fludarabine, Mitoxantrone and Cyclophosphamide Combination Therapy in Relapsed Chronic Lymphocytic Leukemia with or without G-CSF Results of the First Interim Ananlysis of a Phase III Study of the German CLL Study Group
2002
Blood
Schmitt B
Astrid Franke
Oswald Burkhard
Rudolf Schlag
Georg Hopfinger
Martina Stauch
Manuela Bergmann
Clemens-M. Wendtner
Raymonde Busch
Bertold Emmerich
Michael Hallek
Gcllsg
Show All
Source
Cite
Save
Citations (4)
1